Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
|
US |
|
T
|
Tempore Properties SOCIMI SAU
MAD:YTEM
|
ES |
|
Cerberus Cyber Sentinel Corp
NASDAQ:CISO
|
US |
|
P
|
Pardus Girisim Sermayesi Yatirim Ortakligi AS
IST:PRDGS.E
|
TR |
|
D
|
Douzone Bizon Co Ltd
KRX:012510
|
KR |
|
M
|
Meta Corporation PCL
SET:META
|
TH |
|
National Beverage Corp
NASDAQ:FIZZ
|
US |
|
Artmarket.com SA
PAR:PRC
|
FR |
|
G
|
Gemini Space Station Inc
NASDAQ:GEMI
|
US |
|
A
|
Accelera Innovations Inc
OTC:ACNV
|
US |
|
Q
|
QTC Energy PCL
SET:QTC
|
TH |
|
Yakutskenergo PAO
MOEX:YKEN
|
RU |
|
I
|
ITV PLC
OTC:ITVPY
|
UK |
|
M
|
Mckesson Corp
F:MCK
|
US |
|
KTL Global Ltd
SGX:EB7
|
SG |
|
A
|
Ault Alliance Inc
AMEX:AULT
|
US |
|
Smart Sand Inc
NASDAQ:SND
|
US |
|
Fuller Smith & Turner PLC
LSE:FSTA
|
UK |
|
Emmessar Biotech and Nutrition Ltd
BSE:524768
|
IN |
|
Green Cures & Botanical Distribution Inc
OTC:GRCU
|
US |
|
K
|
KCC Engineering & Construction Co Ltd
KOSDAQ:021320
|
KR |
|
Sanofi SA
OTC:SNYNF
|
FR |
|
R
|
Retech Technology Co Ltd
ASX:RTE
|
CN |
Shareholder Yield
Current shareholder yield for DAWN is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
DAWN Price
Day One Biopharmaceuticals Inc
| Average Annual Return | -14.34% |
| Standard Deviation of Annual Returns | 21.94% |
| Max Drawdown | -80% |
| Market Capitalization | 2.2B USD |
| Shares Outstanding | 103 300 000 |
| Percentage of Shares Shorted | 11.55% |
